BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02268851-completion@plaintrial.com
DTSTAMP:20261028T065236Z
DTSTART;VALUE=DATE:202210
SUMMARY:A Phase I/Ib Safety and Efficacy Study of the PI3K-delta Inhibitor 
 TGR-1202 and Ibrutinib in Patients With CLL or MCL — estimated completio
 n date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT02268851
URL:https://plaintrial.com/trial/NCT02268851
END:VEVENT
END:VCALENDAR